Printer Friendly

Musculoskeletal Transplant Foundation, Stryker Biotech sign joint agreement to market products used in treatment of bone and joint tissue.

The Musculoskeletal Transplant Foundation (MTF), Edison, NJ, and Stryker Biotech, a division of the Stryker Corporation, announced they have signed an exclusive joint development agreement focused on the development and marketing of products combining allograft tissue and OP-1, Stryker's proprietary bone morphogenetic protein, for use in the treatment, repair and replacement of bone and joint tissue. Under terms of the agreement, MTF and Stryker Biotech will immediately begin to evaluate the safety and efficacy of the combined products in a variety of indications.

Stryker says it believes OP-1 may work well in the replacement of bone. The companies believe the combined technologies have the potential to increase the utility and efficacy of bone used in transplantation. Contac: Bruce Stroever, MTF - (732) 661-0202; David Simpson, Stryker - (616) 385-2600
COPYRIGHT 1998 Transplant Communications, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1998 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Transplant News
Geographic Code:1USA
Date:Sep 30, 1998
Words:127
Previous Article:Chemotherapy for cancer causes number of British children to need heart transplants.
Next Article:Congress oks one-year delay on implementation of HHS OPTN regulation in final hours of budget debate.
Topics:


Related Articles
Lifecore Biomedical, MTF form distribution alliance.
MTF announces release of newly patented demineralized bone matrix allograft tissue product.
Aztec completes fit-out assignment. (Design and Development).
MTF, Aastrom form partnership to develop novel treatments for tissue regeneration.
Aastrom received FDA approval to initiate multi-center trial for bone graft product.
Nabi acquires exclusive rights to Phase III organ transplantation rejection antibody product.
Infection Prompts Recall of Donor Tissue.
Dubai Bone and Joint Center Celebrates International Physiotherapy Day.

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters |